Page last updated: 2024-12-05
piperonyl alcohol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
piperonyl alcohol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 10322 |
| CHEBI ID | 167431 |
| SCHEMBL ID | 49914 |
| MeSH ID | M0123332 |
Synonyms (66)
| Synonym |
|---|
| einecs 207-808-4 |
| benzyl alcohol, 3,4-(methylenedioxy)- |
| unii-4163k563gs |
| 4163k563gs , |
| hsdb 8494 |
| heliotropyl alcohol |
| nsc 26265 |
| ai3-05702 |
| CHEBI:167431 |
| 1,3-benzodioxol-5-yl-methanol |
| nsc26265 |
| nsc-26265 |
| benzyl alcohol,4-(methylenedioxy)- |
| piperonol |
| piperonyl alcohol |
| 1-hydroxymethyl-3,4-methylenedioxybenzene |
| 1,3-benzodioxole-5-methanol |
| 3,4-methylenedioxybenzyl alcohol |
| 495-76-1 |
| 5-hydroxymethyl-1,3-benzodioxole |
| SDCCGMLS-0065920.P001 |
| benzo[1,3]dioxol-5-ylmethanol |
| DALC2-H_000040 |
| 1,3-benzodioxol-5-ylmethanol |
| AP-065/40214405 |
| inchi=1/c8h8o3/c9-4-6-1-2-7-8(3-6)11-5-10-7/h1-3,9h,4-5h |
| piperonyl alcohol, 98% |
| STK397489 |
| P0457 |
| helioalcohol |
| (1,3-benzodioxol-5-yl)methanol |
| AKOS000119342 |
| BBL011934 |
| AM803952 |
| benzo[d][1,3]dioxol-5-ylmethanol |
| FT-0614397 |
| 3,4-(methylenedioxy)benzenemethanol |
| benzo(1,3)dioxol-5-ylmethanol |
| 3,4-methylenedioxyphenylmethanol |
| (benzodioxol-5-yl)methanol |
| SCHEMBL49914 |
| (2h-1,3-benzodioxol-5-yl)methanol |
| FS-1186 |
| 3,4 -methylendioxy-benzylalcohol |
| 3,4-methylenedioxyphenyl methanol |
| 3,4-(methylenedioxy)-benzyl alcohol |
| 3,4-(methylenedioxy)benzyl alcohol |
| benzo[1,3]dioxol-5-yl-methanol |
| 3,4-(methylenedioxy)phenylmethanol |
| benz[1,3]dioxol-5-yl-methanol |
| 3,4-methylendioxy-benzylalcohol |
| 3,4-methylendioxybenzylalcohol |
| 3,4-methylenedioxy-benzyl alcohol |
| 3,4-methylenedioxy benzyl alcohol |
| DTXSID3060089 |
| piperonylalkohol |
| F0001-1287 |
| mfcd00005836 |
| piperonylalcohol |
| SY033132 |
| 1,3-benzodioxol-5-ylmethanol; helioalcohol |
| (1,3-dioxaindan-5-yl)methanol |
| EN300-20232 |
| 5-(hydroxymethyl)-1,3-benzodioxole |
| Q27258401 |
| Z104477372 |
Research Excerpts
Toxicity
| Excerpt | Reference | Relevance |
|---|---|---|
| " With worker ants the toxic effects started with compound 5 and increased with the number of carbons in the side chain." | ( Toxicity of synthetic piperonyl compounds to leaf-cutting ants and their symbiotic fungus. Bacci Júnior, M; Bueno, FC; Bueno, OC; Correa, AG; Crisóstomo, FR; da Silva, MF; Fernandes, JB; Hebling, MJ; Pagnocca, FC; Victor, SR; Vieira, PC, 2001) | 0.31 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
| Class | Description |
|---|---|
| benzodioxoles | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Bioassays (2)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 33.43
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (33.43) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||